Company Valuation: Theracryf Plc

Data adjusted to current consolidation scope
Fiscal Period: March 2021 2022 2023 2024 2025 2026 2027
Market Cap 1 28.21 12.65 12.58 3.919 6.191 6.021 -
Change - -55.17% -0.51% -68.86% 57.98% -2.74% -
Enterprise Value (EV) 1 11.85 1.317 6.354 1.358 3.34 3.87 6.474
Change - -88.89% 382.62% -78.63% 145.93% 15.88% 67.3%
P/E -4x -3.7x -2.51x -0.76x -0.6x -1.41x -1.72x
PBR 1.69x 1.09x 1.89x 0.96x 0.19x 1.55x -
PEG - 0.1x -0.1x 0x 0x 0x 0.1x
Capitalization / Revenue 103x - 22.9x 7.75x - - -
EV / Revenue 43.3x - 11.6x 2.68x - - -
EV / EBITDA -2.63x -0.33x -1.01x -0.3x -1.3x -0.79x -
EV / EBIT -2.61x -0.33x -1x -0.3x -1.16x -0.83x -1.55x
EV / FCF -2.88x -0.34x -1.24x -0.35x -1.04x -1.03x -
FCF Yield -34.8% -297% -80.9% -282% -95.8% -97% -
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.0257 -0.0124 -0.0182 -0.0146 -0.00488 -0.00199 -0.00163
Distribution rate - - - - - - -
Net sales 1 0.2738 - 0.5487 0.5059 - - -
EBITDA 1 -4.508 -3.996 -6.32 -4.54 -2.574 -4.904 -
EBIT 1 -4.534 -4.016 -6.336 -4.555 -2.878 -4.667 -4.187
Net income 1 -3.773 -3.433 -5.019 -4.007 -2.63 -3.351 -3.43
Net Debt 1 -16.36 -11.33 -6.229 -2.561 -2.851 -2.151 0.4535
Reference price 2 0.102634 0.046008 0.045774 0.011061 0.002907 0.002802 0.002802
Nbr of stocks (in thousands) 274,888 274,888 274,888 354,288 2,129,622 2,148,964 -
Announcement Date 6/15/21 6/8/22 6/7/23 5/28/24 6/3/25 - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-1.41x - -0.79x - 6.02M
33.56x8.36x25.84x0.05% 57.28B
20.68x6.37x13.94x1.54% 54.99B
-41.86x13.29x-39.17x-.--% 23.18B
-17.88x4.15x-7.26x-.--% 22.59B
25.74x5.04x13.35x-.--% 20.46B
24.54x4.77x15.5x-.--% 17.56B
-523.64x37.41x-1539.29x-.--% 15.67B
43.58x17.61x45.34x0.08% 14.46B
17.42x5.04x11.77x-.--% 13.92B
Average -41.93x 11.34x -146.08x 0.19% 24.01B
Weighted average by Cap. -19.52x 9.70x -89.86x 0.37%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. EVG Stock
  4. Valuation Theracryf Plc